567
Views
14
CrossRef citations to date
0
Altmetric
Reviews

Emerging drugs for Guillain-Barré syndrome

, MD, , MD & , MD
Pages 105-120 | Published online: 25 Feb 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Shuang Liu, Chaoling Dong & Eroboghene Ekamereno Ubogu. (2018) Immunotherapy of Guillain-Barré syndrome. Human Vaccines & Immunotherapeutics 14:11, pages 2568-2579.
Read now
Paula Restrepo-Jiménez, Yhojan Rodríguez, Paulina González, Christopher Chang, M. Eric Gershwin & Juan-Manuel Anaya. (2018) The immunotherapy of Guillain-Barré syndrome. Expert Opinion on Biological Therapy 18:6, pages 619-631.
Read now

Articles from other publishers (12)

Mustafa Saleh, Mona Boukhdoud, Hayam Boukhdoud, Mohammad Al Zein & Pascale Salameh. (2023) Landscape of Guillain–Barré Syndrome Interventional Clinical Trials. Journal of Clinical Neuromuscular Disease 24:3, pages 119-129.
Crossref
Yhojan Rodríguez, Christopher Chang, Diana C. González-Bravo, M. Eric Gershwin & Juan-Manuel Anaya. 2019. Neuroimmune Diseases. Neuroimmune Diseases 711 736 .
Zhongqian Su, Zhibo Chen, Yian Xiang, Bingjie Wang, Yuanyuan Huang, Dehao Yang, Xiang Li, Yiyun Weng, XianFeng Lin, Guoqian Chen, Wenyue Liu, Chenchen Zhao, Qingqing Wang, Shanshan Li, Ying Chen, Ying Chen, Weiwei Quan, Qiuling Tong, Shengjie Wu, Shihao Huang, Peina Mei, Zhengzheng Li, Jia Li, Shengtao Hou & Xu Zhang. (2017) Low serum levels of uric acid and albumin in patients with Guillain–Barre syndrome. Medicine 96:15, pages e6618.
Crossref
Elena E. Perez, Jordan S. Orange, Francisco Bonilla, Javier Chinen, Ivan K. Chinn, Morna Dorsey, Yehia El-Gamal, Terry O. Harville, Elham Hossny, Bruce Mazer, Robert Nelson, Elizabeth Secord, Stanley C. Jordan, E. Richard Stiehm, Ashley A. Vo & Mark Ballow. (2017) Update on the use of immunoglobulin in human disease: A review of evidence. Journal of Allergy and Clinical Immunology 139:3, pages S1-S46.
Crossref
Pallavi Asthana, Joaquim Si Long Vong, Gajendra Kumar, Raymond Chuen-Chung Chang, Gang Zhang, Kazim A. Sheikh & Chi Him Eddie Ma. (2015) Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barr? Syndrome: an Animal Model Approach. Molecular Neurobiology 53:7, pages 4981-4991.
Crossref
Ernesto Doncel-Pérez, Lourdes Mateos-Hernández, Eduardo Pareja, Ángel García-Forcada, Margarita Villar, Raquel Tobes, Francisco Romero Ganuza, Virginia Vila del Sol, Ricardo Ramos, Isabel G. Fernández de Mera & José de la Fuente. (2016) Expression of Early Growth Response Gene-2 and Regulated Cytokines Correlates with Recovery from Guillain–Barré Syndrome. The Journal of Immunology 196:3, pages 1102-1107.
Crossref
B. Paul Morgan & Claire L. Harris. (2015) Complement, a target for therapy in inflammatory and degenerative diseases. Nature Reviews Drug Discovery 14:12, pages 857-877.
Crossref
Marcia B. Smith & Nancy Mulligan. (2014) Peripheral Neuropathies and Exercise. Topics in Geriatric Rehabilitation 30:2, pages 131-147.
Crossref
Dimitrios Tzachanis, Ayad Hamdan, Erik J. Uhlmann & Robin M. Joyce. (2014) Successful Treatment of Refractory Guillain-Barré Syndrome with Alemtuzumab in a Patient with Chronic Lymphocytic Leukemia. Acta Haematologica 132:2, pages 240-243.
Crossref
Helmar C. Lehmann, Richard A. C. Hughes, Bernd C. Kieseier & Hans-Peter Hartung. (2012) Recent developments and future directions in Guillain-Barré syndrome. Journal of the Peripheral Nervous System 17:s3, pages 57-70.
Crossref
T. Kuntzer. (2012) Revue de la littérature 2011 : neuropathies dysimmunitaires. Revue Neurologique 168:12, pages 975-978.
Crossref
Damien Biotti, Catherine Vignal, Tarek Sharshar, Oliver Gout, Allison N. McCoy & Neil R. Miller. (2012) Blindness, Weakness, and Tingling. Survey of Ophthalmology 57:6, pages 565-572.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.